Effectiveness and safety of glycoprotein IIb/IIIa inhibitors in patients with myocardial infarction undergoing primary percutaneous coronary intervention: A meta-analysis of observational studies

International Journal of Cardiology

Volumn 153, Issue 3, 2011, Pages 249-255

  Kouz, Remi ^a   Kouz, Simon ^b   Schampaert, Erick ^c   Rinfret, Stephane ^d   Tardif, Jean Claude ^e   Nguyen, Michel ^f   Eisenberg, Mark ^g   Harvey, Richard ^f   Afilalo, Marc ^g   Lauzon, Claude ^h   Dery, Jean Pierre ^d   Mansour, Samer ⁱ   Huynh, Thao ^j  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Centre Hospitalier Regional de Lanaudiere   (Canada)

^c HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^d LAVAL UNIVERSITY   (Canada)

^e MONTREAL HEART INSTITUTE   (Canada)

^f CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^g MCGILL UNIVERSITY   (Canada)

^h Centre Hospitalier de de l'Amiante   (Canada)

ⁱ CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^j MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

more..

Author keywords

Acute coronary syndromes; Angioplasty; Glycoprotein inhibition; Percutaneous coronary intervention

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; EPTIFIBATIDE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TICLOPIDINE; TIROFIBAN;

ADJUVANT THERAPY; ADULT; ARTICLE; BLEEDING; CARDIOVASCULAR DISEASE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORTALITY; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON, CORONARY; HUMANS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 81855185377     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.08.019     Document Type: Article

References (43)

1. M.J. Eisenberg, and S. Jamal Glycoprotein IIb/IIIa inhibition in the setting of acute ST-segment elevation myocardial infarction J Am Coll Cardiol 42 2003 1 6 (Pubitemid 36760754)
2. D.E. Kandzari, V. Hasselblad, and J.E. Tcheng Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systemic overview of randomized clinical trials Am Heart J 147 2004 457 462 (Pubitemid 38880865)
3. G. De Luca, H. Suryapranata, and G.W. Stone Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials JAMA 293 2005 1759 1765
4. J.O. Araujo, H.H. Veloso, and J.M.B. De Paiva Efficacy and safety of abciximab on acute myocardial infarction treated with percutaneous coronary interventions: a meta-analysis of randomized, controlled trials Am Heart J 148 2004 937 943 (Pubitemid 39646964)
5. G. Montalescot, D. Antoniucci, and A. Kastrati Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up Eur Heart J 28 2007 443 449 (Pubitemid 47343560)
6. E.M. Antman, D.T. Anbe, and P.W. Armstrong ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction) Circulation 110 2004 e82 e292
7. E. Bjorklund, B. Lindahl, and U. Stenestrand Outcome of ST-elevation myocardial infarction treated with thrombolysis in the unselected population is vastly different from samples of eligible patients in a large-scale clinical trial Am Heart J 148 2004 566 573 (Pubitemid 39349373)
8. J.H. Gurwitz, N.F. Col, and J. Avorn The exclusion of the elderly and women from clinical trials in acute myocardial infarction JAMA 268 1992 1417 1422
9. P.Y. Lee, K.P. Alexander, and B.G. Hammill Representation of elderly persons and women in published randomized trials of acute coronary syndromes JAMA 286 2001 708 713 (Pubitemid 33010364)
10. J. Concato, N. Shah, and R.I. Horwitz Randomized, controlled trials, observational studies, and the hierarchy of research designs N Engl J Med 342 2000 1887 1892 (Pubitemid 30419054)
11. P.N. Papanikolaou, G.D. Christidi, and J.P.A. Ioannidis Comparison of evidence on harms of medical interventions in randomized and non-randomized studies CMAJ 174 2006 635 641 (Pubitemid 43341873)
12. I. Shrier, J.F. Boivin, and R.J. Steele Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles Am J Epidemiol 166 2007 1203 1209 (Pubitemid 350022749)
13. P.L. Santaguida, M. Helfand, and P. Rains Challenges in systematic reviews that evaluate drug efficacy or effectiveness Ann Intern Med 142 2005 1006 1072
14. K.A. Eagle, B.K. Nallamothu, and R.H. Mehta Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go Eur Heart J 29 2008 609 617
15. C.M. Gibson, Y.B. Pride, and P.D. Frederick Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006 Am Heart J 156 2008 1035 1044
16. M.S. Lauer, and E.J. Topol Clinical trials-multiple treatments, multiple endpoints and multiple lessons JAMA 289 2003 2575 2577 (Pubitemid 37430160)
17. P. Juni, A. Witschi, R. Bloch, and M. Egger The hazards of scoring the quality of clinical trials for meta-analysis JAMA 282 1999 1054 1060 (Pubitemid 29436453)
18. E.M. Balk, P.A.L. Bonis, and H. Moskowitz Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials JAMA 287 2002 2973 2981
19. D.F. Stroup, J.A. Berlin, and S.C. Morton Meta-analysis of observational studies in epidemiology. A proposal for reporting JAMA 283 2000 208 212
20. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188 (Pubitemid 17189972)
21. J.J. Deeks, D.G. Altman, and M.J. Bradburn Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis Systematic Reviews in Health Care: Meta-analysis in Context-Second Edition British Medical Journal 2001 3 19
22. J.S. Berger, and D.L. Brown Association of glycoprotein IIb/IIIa inhibitors and long-term survival following administration during percutaneous coronary intervention for acute myocardial infarction J Thromb Thrombolysis 21 2006 229 234 (Pubitemid 43676779)
23. H. Uyarel, B. Uzunlar, and S. Unal Dayi Effect of tirofiban therapy on ST segment resolution and clinical outcomes in patients with ST segment elevated acute myocardial infarction undergoing primary angioplasty Cardiology 105 2006 168 175
24. T. Heer, U. Zeymer, and C. Juenger Beneficial effects of abciximab in patients with primary percutaneous intervention for acute ST segment elevation myocardial infarction in clinical practice Heart 92 2006 1484 1489 (Pubitemid 44578849)
25. S. Lavi, L. Gruberg, and M. Kapeliovich The impact of GP IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction patients J Invasive Cardiol 17 2005 296 299 (Pubitemid 41724825)
26. V.G. Kalaria, I. Chaudhary, and S. Jacobson Evolution in the practice of primary angioplasty: effect of adjunctive coronary stenting and glycoprotein IIb/IIIa inhibitors on long-term outcomes Catheter Cardiovasc Interv 54 2001 327 332
27. D. Antoniucci, R. Valenti, and A. Migliorini Abciximab therapy improves 1-month survival rate in unselected patients with acute myocardial infarction undergoing routine infarct artery stent implantation Am Heart J 144 2002 315 322 (Pubitemid 34879657)
28. S. Giri, J.F. Mitchel, and J.A. Hirst Synergy between intracoronary stenting and abciximab in improving angiographic and clinical outcomes of primary angioplasty in acute myocardial infarction Am J Cardiol 86 2000 269 274 (Pubitemid 30462219)
29. R.H. Azar, R.G. McKay, and P.D. Thompson Abciximab in primary coronary angioplasty for acute myocardial infarction improves short- and medium-term outcomes J Am Coll Cardiol 32 1998 1996 2002 (Pubitemid 29010467)
30. A.W. Chan, D.P. Chew, and D.L. Bhatt Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction Am J Cardiol 89 2002 132 136 (Pubitemid 34132898)
31. E.I. Lev, R. Kornowski, and I. Teplisky The impact of adjunctive eptifibatide therapy with percutaneous coronary intervention for acute myocardial infarction Int J Cardiovasc Interv 7 2005 41 45 (Pubitemid 40780427)
32. V.S. Srinivas, B. Skeif, and A. Negassa Effectiveness of glycoprotein IIb/IIIa inhibitor use during primary coronary angioplasty: results of propensity analysis using the New York State Percutaneous Coronary Intervention Reporting System Am J Card 99 2007 482 485 (Pubitemid 46215555)
33. F.J. Newman, A. Kastrati, and C. Schimitt Effect of glycoprotein IIb/IIIa blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction J Am Coll Cardiol 35 2000 915 921 (Pubitemid 30189922)
34. A.S. Petronio, G. Musemci, and U. Limbruno Abciximab improves 6-month clinical outcome after rescue angioplasty Am Heart J 143 2002 334 341
35. D. Antoniucci, A. Rodriguez, and A. Hempel A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction J Am Coll Cardiol 42 2003 1879 1885 (Pubitemid 37485558)
36. G. Montalescot, P. Barragan, and O. Wittemberg Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction N Engl J Med 344 2001 1895 1903 (Pubitemid 32553358)
37. G.W. Stone, C.L. Grines, and D.A. Cox Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction N Engl J Med 346 2002 957 966 (Pubitemid 34983245)
38. Julinda Mehilli, Adnan Kastrati, and Stefanie Schulz Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial Circulation 119 2009 1933 1940
39. Michel R. May, George A. Wells, and Chris A. Glover Primary percutaneous coronary angioplasty with and without eptifibatide in ST-segment elevation myocardial infarction: a safety and efficacy study of integrilin-facilitated versus primary percutaneous coronary intervention in ST-segment elevation myocardial infarction (ASSIST) Circ Cardiovasc Interv 2 2009 330 338
40. Arnoud W.J. van't Hof, Jurriën ten Berg, and Ton Heestermans Prehospital initiation of tirofi ban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial Lancet 372 2008 537 546
41. H.S. Gurm, U. Tamhane, and P. Meier A comparison of abciximab and small-molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials Circ Cardiovasc Interv 2 3 2009 230 236
42. M. Egger, G. Davey Smith, and M. Schneider Bias in meta-analysis detected by a simple graphical test BMJ 315 1997 629 634 (Pubitemid 27387172)
43. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150